Weak outlook from Pfizer overshadows 4Q performance
NEW YORK (AP) - Pfizer's strong profit for the fourth quarter is being overshadowed by a tepid outlook for the year.
More from Virginia Business
Virginia Lawyers Weekly
Securities claims can't be based on puffery, boasting
Virginia Business
•
Dec 5, 2022
Virginia Lawyers Weekly
022-2-247 -- Zeigler v. Eastman Chemical Company
Virginia Business
•
Dec 5, 2022
Virginia Lawyers Weekly
Court clarifies 'statutory employees' exception
Virginia Business
•
Dec 5, 2022
Virginia Lawyers Weekly
022-2-243 -- Capps v. Newmark Southern Region LLC
Virginia Business
•
Dec 5, 2022